Neurogene Inc Stock Ownership - Who owns Neurogene?

Insider buying vs selling

Have Neurogene Inc insiders been buying or selling?
Baker Bros Advisors LPDirector2023-08-1761,134$0.69
Baker Bros Advisors LPDirector2023-08-175,041$0.69
Baker Bros Advisors LPDirector2023-08-1793,091$0.69
Baker Bros Advisors LPDirector2023-08-177,676$0.69
Baker Bros Advisors LPDirector2023-08-164,434$0.68
Baker Bros Advisors LPDirector2023-08-16366$0.68
Baker Bros Advisors LPDirector2023-08-16207,676$0.68
Baker Bros Advisors LPDirector2023-08-1617,124$0.68
Baker Bros Advisors LPDirector2023-08-154,342$0.67
Baker Bros Advisors LPDirector2023-08-15358$0.67

1 of 2

NGNE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NGNE insiders and whales buy or sell their stock.

NGNE Shareholders

What type of owners hold Neurogene Inc stock?
Redmile Group LLC29.79%3,866,579$119.90MInsider
Jonathan G. Drachman17.71%2,298,686$71.28MInsider
Gary Bridger14.81%1,922,775$59.63MInsider
Ventures West 8 Limited Partnership11.89%1,543,989$47.88MInsider
Johnson Johnson11.11%1,442,094$44.72MInsider
Carl Walkey10.42%1,352,489$41.94MInsider
Ecor1 Capital LLC9.79%1,271,342$39.42MInstitution
Samsara Biocapital LLC9.77%1,267,790$39.31MInstitution
Rachel McMinn9.63%1,250,359$38.77MInsider
Baker Bros Advisors LP9.21%1,196,081$37.09MInsider

1 of 3

NGNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGNE43.00%57.00%Net Buying
SLRN74.37%25.63%Net SellingNet Selling
RNAC54.76%45.24%Net BuyingNet Buying
ENGN71.68%27.54%Net BuyingNet Selling

Neurogene Stock Ownership FAQ

Who owns Neurogene?

Neurogene (NASDAQ: NGNE) is owned by 93.45% institutional shareholders, 123.87% Neurogene insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Neurogene shareholder, owning 3.87M shares representing 29.79% of the company. Redmile Group LLC's Neurogene shares are currently valued at $119.90M.

If you're new to stock investing, here's how to buy Neurogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.